Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05029557
Other study ID # HasanKU-SAZAK-001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 27, 2021
Est. completion date July 10, 2022

Study information

Verified date February 2024
Source Hasan Kalyoncu University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Individuals who have COPD need a nursing service, which provides qualified and effective professional care, self-care, and supportive care to perform their daily life activities, and improve their quality of life. It is predicted that the Chronic Care-Based Training Program to be implemented and the follow-ups can increase the level of self-efficacy and satisfaction, and raise awareness on the management of the disease in patients. The purpose of the study was to evaluate the effects of the Chronic Care Model based education and telephone follow-up given to patients with COPD on self-efficacy and patient-reported outcomes. Also, the Modified Patient-Reported Outcome Scale for Chronic Obstructive Pulmonary Disease-mCOPD-PRO scale, which will be used in the study, will be adapted into Turkish language and culture, and will be used in the study after its validity and reliability are examined.


Description:

Chronic Obstructive Pulmonary Disease is a major global healthcare problem with its high prevalence, increasing incidence (partly due to population aging), and major serious personal, social, and economic costs. Individuals who have COPD require a nursing service that provides qualified and effective professional care, self-care, and supportive care to perform their daily life activities and improve their quality of life. Nurses have active roles in the management of COPD as professional members of the team, and perform the roles of caregiving, consultancy, researcher, manager, and trainer in COPD management. The skills needed for the management of COPD and the knowledge and interventions to develop these skills are conceptualized as self-management, which is a complex structure including drug compliance, smoking cessation, maintaining and increasing exercise capacity, healthy lifestyle changes that include nutrition regulation, vaccination, and symptom management. The purpose of "Self-management" in COPD is stated in the GOLD 2021 report as "to provide motivation, encouragement, and guidance for patients to acquire positive health behaviors and to gain the ability to cope with their disease". The Self-Management Training and Guidance provided by healthcare staff must be the basic element of the "Chronic Diseases Care Model" in the scope of the healthcare provided. Although various models were proposed for chronic disease management, the best known, most used, and most effective among these is the Chronic Care Model. The model has the quality of being a roadmap for high-quality and patient-centered service delivery in chronic diseases. Four components of the Chronic Care Model will be implemented in the present study, which are; Decision Making Support, Self-Management Support, Health Services Delivery Plan, and Clinical Information Systems. The study has a randomized controlled experimental study design. The sampling of the study will consist of the patients who were diagnosed with COPD, hospitalized in Elbistan State Hospital Chest Policlinic of Kahramanmaraş Provincial Health Directorate, met the inclusion criteria, and who volunteer to participate in the study. A total of 66 patients, 33 in the Control Group, and 33 in the Intervention Group will be randomized into groups in the computer medium. According to the intervention protocol of the study, 1. A training booklet will be created for COPD patients in the scope of the Chronic Care Model self-management support component of the study. The quality of the booklet will be evaluated by submitting it to expert opinions. 2. Patients who meet the inclusion criteria will be included in the present study as the Intervention and Control Group according to the randomization list. 3. Patients in the Control and Intervention Group will be interviewed and their pre-test data will be collected after informed consent is obtained from them. For this purpose, Patient Information Form, COPD Self-Efficacy Scale, 6MWT, COPD Assessment Test (CAT),modified Medical Research Council (mMRC) Dyspnea Scale, Modified Patient-Reported Outcome Scale for Chronic Obstructive Pulmonary Disease (mCOPD-PRO) Scale will be used. 4. After the pre-tests are completed, the patients in the Intervention Group will be given training (0 months) with the training booklet, which is prepared by the researcher based on the Chronic Care Model, and which includes information and suggestions about self-management strategies. The training will be organized in one single session in a way not to exceed approximately 45-50 minutes. 5. The patients, who will be included in the Intervention Group, will be followed up by phone every two weeks. Also, reminders and informative information based on the training booklet will be sent to patients every week in the form of a short message. 6. The patients in the Control Group will continue their routine procedures. 7. Post-tests will be applied to the patients who will be included in the Control and Intervention Group at the 3rd-month polyclinic follow-up. The Patient Assessment of Chronic Illness Care (PACIC) will be used in this post-test in addition to the pre-tests. At the end of the study, Training will be given to the Control Group patients along with Training Booklet.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date July 10, 2022
Est. primary completion date July 10, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years and older, - Confirmed COPD diagnosis - Ability to communicate and literate - Able to communicate by phone - Volunteering to participate in the research. Exclusion Criteria: - Being closed to communication - Unable to communicate by phone - Not being a volunteer

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Education and telephone follow ups based on the Chronic Care Model
The effects of Chronic Care Model-based education and telephone follow-up given to patients with COPD on self-efficacy and patient-reported outcomes.

Locations

Country Name City State
Turkey Hasan Kalyoncu University Gaziantep

Sponsors (1)

Lead Sponsor Collaborator
Hasan Kalyoncu University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of self-efficacy status The COPD Self-Efficacy Scale consists of 34 items and 5 subscales, and is used to determine the degree of confidence of COPD patients in managing or avoiding breathing difficulties in certain activities. The sub-factors of the scale consist of negative impact, emotional state, physical effort, weather/environment effect, and behavioral risk factors. On the scale, as the mean score increases, the degree of confidence also increases in managing or avoiding respiratory distress. 0 months
Primary Evaluation of self-efficacy status The COPD Self-Efficacy Scale consists of 34 items and 5 subscales, and is used to determine the degree of confidence of COPD patients in managing or avoiding breathing difficulties in certain activities. The sub-factors of the scale consist of negative impact, emotional state, physical effort, weather/environment effect, and behavioral risk factors. On the scale, as the mean score increases, the degree of confidence also increases in managing or avoiding respiratory distress. 3 months
Primary Evaluation of patient-reported results Modified Patient-Reported Outcome Scale for Chronic Obstructive Pulmonary Disease-mCOPD-PRO; The Turkish version of the scale will be used in the research after being adapted to the Turkish language and culture and examining its validity and reliability by the researcher. The scale consists of 27 items and physiological (17 items), psychological (7 items), and environmental (3 items) fields. The mCOPD-PRO is not a mere measurement of symptoms, it is a comprehensive measurement of disease-specific health status including physiological, psychological, and environmental domains. Each item consists of a 5-point Likert-type design, and the scores of the scale are graded between 0-4. 0 months
Primary Evaluation of patient-reported results Modified Patient-Reported Outcome Scale for Chronic Obstructive Pulmonary Disease-mCOPD-PRO; The Turkish version of the scale will be used in the research after being adapted to the Turkish language and culture and examining its validity and reliability by the researcher. The scale consists of 27 items and physiological (17 items), psychological (7 items), and environmental (3 items) fields. The mCOPD-PRO is not a mere measurement of symptoms, it is a comprehensive measurement of disease-specific health status including physiological, psychological, and environmental domains. Each item consists of a 5-point Likert-type design, and the scores of the scale are graded between 0-4. 3 months
Secondary The Patient Assessment of Chronic Illness Care The Patient Assessment of Chronic Illness Care (PACIC) is a relatively brief 20-item questionnaire designed to assess the extent to which care is aligned with the Chronic Care Model. It consists five factors and, 20-item. The increase in the scale scores shows that individuals with chronic disease are highly satisfied with the care they receive. 3 months
See also
  Status Clinical Trial Phase
Completed NCT05043428 - The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD N/A
Completed NCT00528996 - An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler. Phase 2
Completed NCT03740373 - A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate Phase 1
Completed NCT05393245 - Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
Completed NCT05402020 - Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
Completed NCT04011735 - Re-usable Respimat® Soft MistTM Inhaler Study
Enrolling by invitation NCT03075709 - The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
Completed NCT03764163 - Image and Model Based Analysis of Lung Disease Early Phase 1
Completed NCT00515268 - Endotoxin Challenge Study For Healthy Men and Women Phase 1
Completed NCT04085302 - TARA Working Prototype Engagement Evaluation: Feasibility Study N/A
Completed NCT03691324 - Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study N/A
Completed NCT02236611 - A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT00153075 - Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT01017952 - A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT01009463 - A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT04882124 - Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD Phase 2
Completed NCT02853123 - Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients Phase 4
Completed NCT02619357 - Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma Phase 1
Recruiting NCT05858463 - High Intensity Interval Training and Muscle Adaptations During PR N/A
Not yet recruiting NCT05032898 - Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II